Rating History for Corcept Therapeutics (CORT) by UBS

More Stocks Rated by UBS | Latest Ratings for CORT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/13/2026 Ashwani Verma Upgrade Neutral
(N/A)		 72.00
(44.00)		 51.20
(79.91)		 56.07% Details